Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alcoholism

Free Subscription Articles published in PLoS One Retrieve available abstracts of 223 articles: HTML format

Single Articles

January 2025
1. DABA C, Debela SA, Gasheya KA, Endawkie A, et al
   Spatial variation and determinant factors of alcohol consumption in Ethiopia: Spatial and multilevel analysis of Ethiopian demographic and health survey.
   PLoS One. 2025;20:e0309943.
   PubMed     Abstract available
   
   
   
2. CARD-GOWERS J, Boniface S, Brown J, Kock L, et al
   Long-term health consequences and costs of changes in alcohol consumption in England during the COVID-19 pandemic.
   PLoS One. 2025;20:e0314870.
   PubMed     Abstract available
   
   
   January 2024
3. POWELL A, Sumnall H, Smith J, Kuiper R, et al
   Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Systematic review of longitudinal studies.
   PLoS One. 2024;19:e0296043.
   PubMed     Abstract available
   
   
   
4. DE BEJCZY A, Lido H, Soderpalm B
   A randomized, double-blind, placebo-controlled, multicentre trial on the efficacy of varenicline and bupropion in combination and alone for treatment of alcohol use disorder: Protocol for the COMB study.
   PLoS One. 2024;19:e0296118.
   PubMed     Abstract available
   
   
   
5. PARADA S, Rubio B, Taschini E, Laqueille X, et al
   Creating a psychosocial intervention combining growth mindset and implementation intentions (GMII) to reduce alcohol consumption: A mixed method approach.
   PLoS One. 2024;19:e0297647.
   PubMed     Abstract available
   
   
   
6. SUHAG A, Webb TL, Holmes J
   Longitudinal clustering of health behaviours and their association with multimorbidity in older adults in England: A latent class analysis.
   PLoS One. 2024;19:e0297422.
   PubMed     Abstract available
   
   
   
7. KHALIFA A, Palu R, Perkins AE, Volz A, et al
   Prenatal alcohol exposure alters expression of genes involved in cell adhesion, immune response, and toxin metabolism in adolescent rat hippocampus.
   PLoS One. 2024;19:e0293425.
   PubMed     Abstract available
   
   
   
8. MCCABE EM, Luk JW, Stangl BL, Schwandt ML, et al
   Exercising healthy behaviors: A latent class analysis of positive coping during the COVID-19 pandemic and associations with alcohol-related and mental health outcomes.
   PLoS One. 2024;19:e0297060.
   PubMed     Abstract available
   
   
   
9. NAIRZ J, Messner A, Kiechl SJ, Winder B, et al
   Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors.
   PLoS One. 2024;19:e0298800.
   PubMed     Abstract available
   
   
   
10. TSUI JI, Rossi SL, Cheng DM, Bendiks S, et al
    Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.
    PLoS One. 2024;19:e0297948.
    PubMed     Abstract available
    
    
    
11. ELGUEZABAL RODELO RG, Porchia LM, Torres-Rasgado E, Lopez-Bayghen E, et al
    Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    PLoS One. 2024;19:e0298662.
    PubMed     Abstract available
    
    
    
12. NILSSON AH, Schwartz HA, Rosenthal RN, McKay JR, et al
    Language-based EMA assessments help understand problematic alcohol consumption.
    PLoS One. 2024;19:e0298300.
    PubMed     Abstract available
    
    
    
13. THOMAS S, Schafer J, Kanske P, Trautmann S, et al
    Patterns of social-affective responses to trauma exposure and their relation to psychopathology.
    PLoS One. 2024;19:e0289664.
    PubMed     Abstract available
    
    
    
14. TUMWEGAMIRE A, Fatch R, Emenyonu NI, Lodi S, et al
    Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    PLoS One. 2024;19:e0300508.
    PubMed     Abstract available
    
    
    
15. CAI W, Qiu T, Hu W, Fang T, et al
    Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis.
    PLoS One. 2024;19:e0299946.
    PubMed     Abstract available
    
    
    
16. POPOVA S, Dozet D, Temple V, McFarlane A, et al
    Fetal alcohol spectrum disorder diagnostic clinic capacity in Canadian Provinces and territories.
    PLoS One. 2024;19:e0301615.
    PubMed     Abstract available
    
    
    
17. FARNIA V, Ahmadi Jouybari T, Salemi S, Moradinazar M, et al
    The prevalence of alcohol consumption and its related factors in adolescents: Findings from Global School-based Student Health Survey.
    PLoS One. 2024;19:e0297225.
    PubMed     Abstract available
    
    
    
18. SHCHETININA A, Slopen N
    Unmet need for alcohol use disorder treatment in reproductive-age females, with emphasis on pregnant and parenting populations in the United States: Findings from NSDUH 2015-2021.
    PLoS One. 2024;19:e0301810.
    PubMed     Abstract available
    
    
    
19. CHAVEZ-TAPIA NC, Sanchez-Jimenez BA, Vidana-Perez D, Corrales-Rosas B, et al
    Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    PLoS One. 2024;19:e0290632.
    PubMed     Abstract available
    
    
    
20. JOSE R, Wang W, Sherman G, Rosenthal RN, et al
    Tapping into alcohol use during COVID: Drinking correlates among bartenders and servers.
    PLoS One. 2024;19:e0300932.
    PubMed     Abstract available
    
    
    
21. LIN YH, Zhang ZJ, Zhong JQ, Wang ZY, et al
    Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0302155.
    PubMed     Abstract available
    
    
    
22. HAVLIK JL, Rhee TG, Rosenheck RA
    Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances.
    PLoS One. 2024;19:e0302544.
    PubMed     Abstract available
    
    
    
23. FUNUYET-SALAS J, Martin-Rodriguez A, Perez-San-Gregorio MA, Vale L, et al
    Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom.
    PLoS One. 2024;19:e0300362.
    PubMed     Abstract available
    
    
    
24. GRIMES KEL, Ebasone PV, Dzudie A, Nash D, et al
    Intimate partner violence, depression, hazardous alcohol use, and social support among people with HIV initiating HIV care in Cameroon.
    PLoS One. 2024;19:e0304114.
    PubMed     Abstract available
    
    
    
25. KESSEL K, Forsblom E, Ruotsalainen E, Jarvinen A, et al
    Staphylococcus aureus bacteremia in alcoholics.
    PLoS One. 2024;19:e0298612.
    PubMed     Abstract available
    
    
    
26. KRAMER T, Groh G, Stuben N, Soyka M, et al
    Analysis of addiction craving onset through natural language processing of the online forum Reddit.
    PLoS One. 2024;19:e0301682.
    PubMed     Abstract available
    
    
    
27. TEVIK K, Skrastad RB, Benth JS, Selbaek G, et al
    Prevalence and change in alcohol consumption in older adults over time, assessed with self-report and Phosphatidylethanol 16:0/18:1 -The HUNT Study.
    PLoS One. 2024;19:e0304714.
    PubMed     Abstract available
    
    
    
28. PIACENTINO D, Vizioli C, Barb JJ, Grant-Beurmann S, et al
    Gut microbial diversity and functional characterization in people with alcohol use disorder: A case-control study.
    PLoS One. 2024;19:e0302195.
    PubMed     Abstract available
    
    
    
29. ABIRI P, Jeong ISD, Verdell A, Shah S, et al
    Improvement in inpatient discharge planning for patients with alcohol use disorder with the implementation of a team-based multidisciplinary workflow.
    PLoS One. 2024;19:e0306066.
    PubMed     Abstract available
    
    
    
30. BEYNA AT, Mengesha AK, Yefter ET, Kahaliw W, et al
    Evaluation of wound healing and anti-inflammatory activity of hydro-alcoholic extract and solvent fractions of the leaves of Clerodendrum myricoides (Lamiaceae) in mice.
    PLoS One. 2024;19:e0306766.
    PubMed     Abstract available
    
    
    
31. YOUNG AS, Reboussin BA, Riehm K, Mojtabai R, et al
    Associations between mental health & substance use treatment and alcohol use progression and recovery among US women drinkers.
    PLoS One. 2024;19:e0306820.
    PubMed     Abstract available
    
    
    
32. SHI Y, Zhang J, Wang Z, Shan F, et al
    The association between alcohol consumption and herpes simplex virus type 2: A cross-sectional study from national health and nutrition examination survey 2009-2016.
    PLoS One. 2024;19:e0307702.
    PubMed     Abstract available
    
    
    
33. KIM CR, Kim SY, Kim J, Park EC, et al
    Association between sleep patterns and alcohol use disorders in workers.
    PLoS One. 2024;19:e0308418.
    PubMed     Abstract available
    
    
    
34. ROGES J, Bosque-Prous M, Folch C, Teixido-Compano E, et al
    Effects of social and environmental restrictions, and changes in alcohol availability in adolescents' binge drinking during the COVID-19 pandemic.
    PLoS One. 2024;19:e0309320.
    PubMed     Abstract available
    
    
    
35. JEREMIAH RP, Katisi M, Shehu OM
    Alcohol misuse within different socio-ecologies in rural communities of Botswana.
    PLoS One. 2024;19:e0306542.
    PubMed     Abstract available
    
    
    
36. SANCERNI-BEITIA MD, Motos-Selles P, Gimenez-Costa JA, Cortes-Tomas MT, et al
    A short version of the Alcohol Consumption Consequences Evaluation Scale (ACCE10).
    PLoS One. 2024;19:e0308918.
    PubMed     Abstract available
    
    
    
37. GOMA M, Ng'ambi WF, Zyambo C
    Predicting harmful alcohol use prevalence in Sub-Saharan Africa between 2015 and 2019: Evidence from population-based HIV impact assessment.
    PLoS One. 2024;19:e0301735.
    PubMed     Abstract available
    
    
    
38. JAIN JP, Ma Y, Dawson-Rose C, Santos GM, et al
    The prevalence and correlates of biomarker positive unhealthy alcohol use among women living with and without HIV in San Francisco, California.
    PLoS One. 2024;19:e0308867.
    PubMed     Abstract available
    
    
    
39. TEKLU SW, Kotola BS, Alemneh HT
    Smoking and alcoholism dual addiction dissemination model analysis with optimal control theory and cost-effectiveness.
    PLoS One. 2024;19:e0309356.
    PubMed     Abstract available
    
    
    
40. GARLAND C, Abdulla N, Lee D, Spiwak R, et al
    The impact of alcohol misuse in trauma patients: A scoping review protocol.
    PLoS One. 2024;19:e0301241.
    PubMed     Abstract available
    
    
    
41. LI J, Zhou Z, Gao G, Zang L, et al
    Effectiveness of exercise intervention in improving physical and mental status of patients with alcohol use disorders: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0311166.
    PubMed     Abstract available
    
    
    
42. DONG J, Li Z, Wang C, Zhang R, et al
    Dietary folate intake and all-cause mortality and cardiovascular mortality in American adults with non-alcoholic fatty liver disease: Data from NHANES 2003 to 2018.
    PLoS One. 2024;19:e0314148.
    PubMed     Abstract available
    
    
    
43. SAMBO D, Kinstler E, Lin Y, Goldman D, et al
    Differential effects of prenatal alcohol exposure on brain growth reveals early upregulation of cell cycle and apoptosis and delayed downregulation of metabolism in affected offspring.
    PLoS One. 2024;19:e0311683.
    PubMed     Abstract available
    
    
    
44. GIL-ALANA LA, Lopez G, Hernandez-Herrera M
    Alcohol consumption in the G7 countries (1960-2021). Permanent versus transitory shocks.
    PLoS One. 2024;19:e0314877.
    PubMed     Abstract available
    
    
    
45. FLANNIGAN K, Edwards DC, Reid D, McFarlane A, et al
    Caregiver approaches, resiliencies, and experiences raising individuals with fetal alcohol spectrum disorder: A study protocol paper.
    PLoS One. 2024;19:e0312692.
    PubMed     Abstract available
    
    
    
46. TAN MG, Wider W, Pang NTP, Lasimbang HB, et al
    Gendered narratives and cultural shifts: A qualitative study on decadal changes in community alcohol consumption.
    PLoS One. 2024;19:e0309378.
    PubMed     Abstract available
    
    
    
47. WANG S, Lu K, Lin L, Li G, et al
    Exploring the mechanism of berberine treatment for atherosclerosis combined with non-alcoholic fatty liver disease based on bioinformatic and experimental study.
    PLoS One. 2024;19:e0314961.
    PubMed     Abstract available
    
    
    
48. KE T, Livingston M, Zhang Y, Pavlyshyn D, et al
    A longitudinal study of alcohol consumption among adults in Victoria, Australia during the COVID-19 pandemic.
    PLoS One. 2024;19:e0313599.
    PubMed     Abstract available
    
    
    January 2023
49. 
    Expression of Concern: Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.
    PLoS One. 2023;18:e0279460.
    PubMed    
    
    
    
50. 
    Expression of Concern: Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 2023;18:e0279807.
    PubMed    
    
    
    
51. KASZTELAN-SZCZERBINSKA B, Zygo B, Rycyk-Bojarzynska A, Surdacka A, et al
    Blood concentrations of mediators released from activated neutrophils are related to the severity of alcohol-induced liver damage.
    PLoS One. 2023;18:e0280068.
    PubMed     Abstract available
    
    
    
52. CHUI Z, Leightley D, Jones M, Landau S, et al
    Mental health problems and admissions to hospital for accidents and injuries in the UK military: A data linkage study.
    PLoS One. 2023;18:e0280938.
    PubMed     Abstract available
    
    
    
53. DAVITKOV P, Hoffman K, Falck-Ytter Y, Wilson B, et al
    Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A population-based study.
    PLoS One. 2023;18:e0280647.
    PubMed     Abstract available
    
    
    
54. GAWRIEH S, Corey KE, Lake JE, Samala N, et al
    Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus.
    PLoS One. 2023;18:e0279685.
    PubMed     Abstract available
    
    
    
55. JONES L, Owens L, Thompson A, Gilmore I, et al
    Informing the development of diagnostic criteria for differential diagnosis of alcohol-related cognitive impairment (ARCI) among heavy drinkers: A systematic scoping review.
    PLoS One. 2023;18:e0280749.
    PubMed     Abstract available
    
    
    
56. SANT ANNA FM, Araujo-Pereira M, Schmaltz CAS, Arriaga MB, et al
    Impact of adverse drug reactions on the outcomes of tuberculosis treatment.
    PLoS One. 2023;18:e0269765.
    PubMed     Abstract available
    
    
    
57. BIANCHI LL, da Silva C, Lazaretti LR, Franca MTA, et al
    What factors matter in the amount of alcohol consumed? An analysis among Brazilian adolescents.
    PLoS One. 2023;18:e0281065.
    PubMed     Abstract available
    
    
    
58. BUTLER JL, Gordon-Larsen P, Steffen LM, Shikany JM, et al
    Associations of 5-year changes in alcoholic beverage intake with 5-year changes in waist circumference and BMI in the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    PLoS One. 2023;18:e0281722.
    PubMed     Abstract available
    
    
    
59. JEONG W
    Comparison of alcohol consumption and tobacco use among Korean adolescents before and during the COVID-19 pandemic.
    PLoS One. 2023;18:e0283462.
    PubMed     Abstract available
    
    
    
60. YOKOYAMA A, Kimura M, Yoshimura A, Matsushita S, et al
    Nonsmoking after simultaneous alcohol abstinence and smoking cessation program was associated with better drinking status outcome in Japanese alcohol-dependent men: A prospective follow-up study.
    PLoS One. 2023;18:e0282992.
    PubMed     Abstract available
    
    
    
61. MATULYTE E, Davidaviciene E, Kancauskiene Z, Diktanas S, et al
    The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
    PLoS One. 2023;18:e0282046.
    PubMed     Abstract available
    
    
    
62. SKRZYNSKI CJ, Creswell KG
    Solitary-specific drinking to cope motives explain unique variance in solitary drinking behavior but not alcohol problems compared to general drinking to cope motives.
    PLoS One. 2023;18:e0282506.
    PubMed     Abstract available
    
    
    
63. MONK RL, Qureshi AW, Richardson GB, Heim D, et al
    UK alcohol consumption during the COVID-19 pandemic: The role of drinking motives, employment and subjective mental health.
    PLoS One. 2023;18:e0283233.
    PubMed     Abstract available
    
    
    
64. GILBERT PA, Soweid L, Holdefer PJ, Kersten S, et al
    Strategies to maintain recovery from alcohol problems during the COVID-19 pandemic: Insights from a mixed-methods national survey of adults in the United States.
    PLoS One. 2023;18:e0284435.
    PubMed     Abstract available
    
    
    
65. FUENTES-BEALS C, Olivares-Costa M, Andres ME, Haeger PA, et al
    Bioinformatic analysis predicts that ethanol exposure during early development causes alternative splicing alterations of genes involved in RNA post-transcriptional regulation.
    PLoS One. 2023;18:e0284357.
    PubMed     Abstract available
    
    
    
66. LADI-AKINYEMI T', Okpue AP, Onigbinde OA, Okafor IP, et al
    Depression and suicidal ideation among undergraduates in state tertiary institutions in Lagos Nigeria.
    PLoS One. 2023;18:e0284955.
    PubMed     Abstract available
    
    
    
67. GENTRY AE, Alexander JC, Ahangari M, Peterson RE, et al
    Case-only exome variation analysis of severe alcohol dependence using a multivariate hierarchical gene clustering approach.
    PLoS One. 2023;18:e0283985.
    PubMed     Abstract available
    
    
    
68. BUYCO DG, Dempsey JL, Scorletti E, Jeon S, et al
    Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism.
    PLoS One. 2023;18:e0281954.
    PubMed     Abstract available
    
    
    
69. KANG SJ, Pei CZ, Lee DH, Ha JE, et al
    A pilot randomized clinical trial of biomedical link with mental health in art therapy intervention programs for alcohol use disorder: Changes in NK cells, addiction biomarkers, electroencephalography, and MMPI-2 profiles.
    PLoS One. 2023;18:e0284344.
    PubMed     Abstract available
    
    
    
70. JACKSON SE, Cox S, Shahab L, Brown J, et al
    Impact of the cost-of-living crisis on the nature of attempts to stop smoking and to reduce alcohol consumption in Great Britain: A representative population survey, 2021-2022.
    PLoS One. 2023;18:e0286183.
    PubMed     Abstract available
    
    
    
71. MITROVIC N, Sabanovic M, Vujovic A, Jovanovic J, et al
    Influence of chronic liver diseases on the course and outcome of COVID-19.
    PLoS One. 2023;18:e0288350.
    PubMed     Abstract available
    
    
    
72. BRADSHAW D, Abramowicz I, Bremner S, Verma S, et al
    Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
    PLoS One. 2023;18:e0288598.
    PubMed     Abstract available
    
    
    
73. KRUGER K, Oedingen C, Kautz A, Langenbacher D, et al
    Lifestyle interventions for patients with non-alcoholic steato-hepatitis-Design, rationale and protocol of the study "target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)".
    PLoS One. 2023;18:e0288905.
    PubMed     Abstract available
    
    
    
74. EVERETT RA, Lewis AL, Kuerbis A, Peace A, et al
    Data driven mixed effects modeling of the dual process framework of addiction among individuals with alcohol use disorder.
    PLoS One. 2023;18:e0265168.
    PubMed     Abstract available
    
    
    
75. CHANDRA R, Srivastava S, Singh A, Mukherjee S, et al
    Locating perpetrators of violence against women in India: An analysis of married men's characteristics associated with intimate partner violence.
    PLoS One. 2023;18:e0289596.
    PubMed     Abstract available
    
    
    
76. STATON CA, Friedman K, Phillips AJ, Minnig MC, et al
    Feasibility of a pragmatic randomized adaptive clinical trial to evaluate a brief negotiational interview for harmful and hazardous alcohol use in Moshi, Tanzania.
    PLoS One. 2023;18:e0288458.
    PubMed     Abstract available
    
    
    
77. PESTI-ASBOTH G, Szilagyi E, Birone Molnar P, Olah J, et al
    Monitoring physiological processes of fast-growing broilers during the whole life cycle: Changes of redox-homeostasis effected to trassulfuration pathway predicting the development of non-alcoholic fatty liver disease.
    PLoS One. 2023;18:e0290310.
    PubMed     Abstract available
    
    
    
78. BLAKE H, Yildirim M, Premakumar V, Morris L, et al
    Attitudes and current practice in alcohol screening, brief intervention, and referral for treatment among staff working in urgent and emergency settings: An open, cross-sectional international survey.
    PLoS One. 2023;18:e0291573.
    PubMed     Abstract available
    
    
    
79. AKWA LG, Smith L, Twiddy M, Abt G, et al
    Associations between physical activity, sedentary behaviour, and alcohol consumption among UK adults: Findings from the Health Behaviours during the COVID-19 pandemic (HEBECO) study.
    PLoS One. 2023;18:e0287199.
    PubMed     Abstract available
    
    
    
80. HUANG Q, Guo J, Zhao H, Zheng Y, et al
    The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.
    PLoS One. 2023;18:e0292881.
    PubMed     Abstract available
    
    
    
81. MONTGOMERY C, Saini P, Schoetensack C, McCarthy M, et al
    Improving access to treatment for alcohol dependence in primary care: A qualitative investigation of factors that facilitate and impede treatment access and completion.
    PLoS One. 2023;18:e0292220.
    PubMed     Abstract available
    
    
    
82. CHACON C, Arteaga I, Martinez-Escude A, Ruiz Rojano I, et al
    Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol.
    PLoS One. 2023;18:e0286586.
    PubMed     Abstract available
    
    
    
83. GUIMARAES RA, de Morais Neto OL, Dos Santos TMB, Mandacaru PMP, et al
    Impact of the program life in traffic and new zero-tolerance drinking and driving law on the prevalence of driving after alcohol abuse in Brazilian capitals: An interrupted time series analysis.
    PLoS One. 2023;18:e0288288.
    PubMed     Abstract available
    
    
    
84. VISSOCI JRN, Friedman K, Caruzzo NM, de Oliveira LP, et al
    Clinical evaluation of the alcohol use disorders identification test (AUDIT) in Moshi, Tanzania.
    PLoS One. 2023;18:e0287835.
    PubMed     Abstract available
    
    
    
85. WEN W, Guo C, Chen Z, Yang D, et al
    Regular exercise attenuates alcoholic myopathy in zebrafish by modulating mitochondrial homeostasis.
    PLoS One. 2023;18:e0294700.
    PubMed     Abstract available
    
    
    
86. ROUSSON V, Trachsel B, Iglesias K, Baggio S, et al
    Evaluating the cost of simplicity in score building: An example from alcohol research.
    PLoS One. 2023;18:e0294671.
    PubMed     Abstract available
    
    
    
87. PURUSHOTHAMA C, Crape BL, Stolyarov V, Jaxybayeva A, et al
    Preloaded combination nicotine replacement therapy for smoking cessation in Kazakhstan: A randomized controlled trial study protocol.
    PLoS One. 2023;18:e0292490.
    PubMed     Abstract available
    
    
    
88. ZHANG B, Zhang R, Deng H, Cui P, et al
    Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial.
    PLoS One. 2023;18:e0294768.
    PubMed     Abstract available
    
    
    
89. SABRI B, Budhathoki C, McFall AM, Mehta SH, et al
    Cumulative violence exposures among men who have sex with men living with HIV in India: Psychosocial correlates of HIV care continuum outcomes.
    PLoS One. 2023;18:e0295225.
    PubMed     Abstract available
    
    
    
90. YOUSSEF L, Salameh P, Sacre H, Akel M, et al
    Association between alexithymia, emotional intelligence, smoking addiction, and alcohol use disorder among a sample of Lebanese adults.
    PLoS One. 2023;18:e0295114.
    PubMed     Abstract available
    
    
    
91. MOUNIKA N, Yadav A, Kamboj P, Banerjee SK, et al
    Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2023;18:e0295839.
    PubMed     Abstract available
    
    
    
92. JIA X, Zhang X, Zhou T, Sun D, et al
    Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China.
    PLoS One. 2023;18:e0295184.
    PubMed     Abstract available
    
    
    
93. PELOSO A, Lacotte S, Gex Q, Slits F, et al
    Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models.
    PLoS One. 2023;18:e0296265.
    PubMed     Abstract available
    
    
    January 2022
94. RADFORD-SMITH DE, Patel PJ, Irvine KM, Russell A, et al
    Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism.
    PLoS One. 2022;17:e0261555.
    PubMed     Abstract available
    
    
    
95. S HASHEMI N, Skogen JC, Sevic A, Thorrisen MM, et al
    A systematic review and meta-analysis uncovering the relationship between alcohol consumption and sickness absence. When type of design, data, and sickness absence make a difference.
    PLoS One. 2022;17:e0262458.
    PubMed     Abstract available
    
    
    
96. POWELL LM, Leider J
    Impact of the Seattle Sweetened Beverage Tax on substitution to alcoholic beverages.
    PLoS One. 2022;17:e0262578.
    PubMed     Abstract available
    
    
    
97. JOLEX A, Kaluwa B
    Crowding Out Effects of Alcohol Consumption Expenditure on Household Resource Allocation in Malawi.
    PLoS One. 2022;17:e0263330.
    PubMed     Abstract available
    
    
    
98. TOVMASYAN A, Monk RL, Heim D
    Towards an affect intensity regulation hypothesis: Systematic review and meta-analyses of the relationship between affective states and alcohol consumption.
    PLoS One. 2022;17:e0262670.
    PubMed     Abstract available
    
    
    
99. ASADULLAH M, Shivashankar R, Shalimar, Kandasamy D, et al
    Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.
    PLoS One. 2022;17:e0263768.
    PubMed     Abstract available
    
    
    
100. THOMAS KL, Root CL, Peterson JM
     Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice.
     PLoS One. 2022;17:e0258557.
     PubMed     Abstract available
     
     
     
101. FERNANDEZ T, Vinuela M, Vidal C, Barrera F, et al
     Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
     PLoS One. 2022;17:e0263931.
     PubMed     Abstract available
     
     
     
102. MORISHITA A, Tadokoro T, Fujihara S, Iwama H, et al
     Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
     PLoS One. 2022;17:e0261310.
     PubMed     Abstract available
     
     
     
103. CHOSY EJ, Edland S, Launer L, White LR, et al
     Midlife alcohol consumption and later life cognitive impairment: Light drinking is not protective and APOE genotype does not change this relationship.
     PLoS One. 2022;17:e0264575.
     PubMed     Abstract available
     
     
     
104. SANTOS MGR, Sanchez ZM, Hughes K, Gee I, et al
     Pre-drinking, alcohol consumption and related harms amongst Brazilian and British university students.
     PLoS One. 2022;17:e0264842.
     PubMed     Abstract available
     
     
     
105. HAMADA S, Takata T, Yamada K, Yamamoto M, et al
     Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
     PLoS One. 2022;17:e0265461.
     PubMed     Abstract available
     
     
     
106. KIMER N, Meldgaard M, Hamberg O, Kronborg TM, et al
     The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.
     PLoS One. 2022;17:e0264278.
     PubMed     Abstract available
     
     
     
107. DONOGHUE K, Hermann L, Brobbin E, Drummond C, et al
     The rates and measurement of adherence to acamprosate in randomised controlled clinical trials: A systematic review.
     PLoS One. 2022;17:e0263350.
     PubMed     Abstract available
     
     
     
108. ANENI EC, Saeed GJ, Bittencourt MS, Cainzos-Achirica M, et al
     Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
     PLoS One. 2022;17:e0266505.
     PubMed     Abstract available
     
     
     
109. CAROL M, Perez-Guasch M, Sola E, Cervera M, et al
     Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
     PLoS One. 2022;17:e0265153.
     PubMed     Abstract available
     
     
     
110. SALMAN M, Kamel MA, El-Nabi SEH, Ismail AHA, et al
     The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis.
     PLoS One. 2022;17:e0265455.
     PubMed     Abstract available
     
     
     
111. SARMADI N, Poustchi H, Ali Yari F, Radmard AR, et al
     Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease.
     PLoS One. 2022;17:e0266227.
     PubMed     Abstract available
     
     
     
112. KUMAR RG, Esterov D, Adams RS, Corrigan JD, et al
     Changes in alcohol use and mood during the COVID-19 pandemic among individuals with traumatic brain injury: A difference-in-difference study.
     PLoS One. 2022;17:e0266422.
     PubMed     Abstract available
     
     
     
113. KOVACS I, Gal BI, Horvath Z, Demeter I, et al
     Externalizing personality characteristics define clinically relevant subgroups of alcohol use disorder.
     PLoS One. 2022;17:e0265577.
     PubMed     Abstract available
     
     
     
114. SUBHANI M, Talat U, Knight H, Morling JR, et al
     Characteristics of alcohol recovery narratives: Systematic review and narrative synthesis.
     PLoS One. 2022;17:e0268034.
     PubMed     Abstract available
     
     
     
115. ACHARYA B, Dhakal C
     Risky health behaviors during the COVID-19 pandemic: Evidence from the expenditures on alcohol, non-alcoholic beverages, and tobacco products.
     PLoS One. 2022;17:e0268068.
     PubMed     Abstract available
     
     
     
116. TAKATS A, Berke G, Gede N, Nemeth BC, et al
     Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
     PLoS One. 2022;17:e0268859.
     PubMed     Abstract available
     
     
     
117. RIVERA AC, LeardMann CA, Rull RP, Cooper A, et al
     Combat exposure and behavioral health in U.S. Army Special Forces.
     PLoS One. 2022;17:e0270515.
     PubMed     Abstract available
     
     
     
118. PARCESEPE AM, Filiatreau LM, Ebasone PV, Dzudie A, et al
     Psychiatric comorbidity and psychosocial stressors among people initiating HIV care in Cameroon.
     PLoS One. 2022;17:e0270042.
     PubMed     Abstract available
     
     
     
119. KIM N, Roh JH, Lee H, Kim D, et al
     The impact of non-alcoholic fatty liver disease on sleep apnea in healthy adults: A nationwide study of Korea.
     PLoS One. 2022;17:e0271021.
     PubMed     Abstract available
     
     
     
120. ZETTERSTROM A, Dahlberg G, Lundqvist S, Hamalainen MD, et al
     Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoring.
     PLoS One. 2022;17:e0271465.
     PubMed     Abstract available
     
     
     
121. JAYATHILAKA R, Athukorala O, Ishara S, Silva D, et al
     Alcohol brings burdens: A global and continent wise study on alcohol consumption and global burden of diseases.
     PLoS One. 2022;17:e0270998.
     PubMed     Abstract available
     
     
     
122. DIESE EL, Raines-Milenkov A, Felini M, Akpan I, et al
     Alcohol use among Congolese Babembe male refugees in Tarrant County: A qualitative study.
     PLoS One. 2022;17:e0272293.
     PubMed     Abstract available
     
     
     
123. DE OLIVEIRA SANTOS EG, Vedana KGG, Barbosa IR
     Prevalence and factors associated with suicidal ideation among farmers.
     PLoS One. 2022;17:e0273625.
     PubMed     Abstract available
     
     
     
124. HEREDIA JE, Sorenson C, Flanagan S, Nunez V, et al
     IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models.
     PLoS One. 2022;17:e0274582.
     PubMed     Abstract available
     
     
     
125. OKOYO C, Njambi E, Were V, Araka S, et al
     Prevalence, types, patterns and risk factors associated with drugs and substances of use and abuse: A cross-sectional study of selected counties in Kenya.
     PLoS One. 2022;17:e0273470.
     PubMed     Abstract available
     
     
     
126. ACHESON LS, Ezard N, Lintzeris N, Dunlop A, et al
     Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.
     PLoS One. 2022;17:e0275371.
     PubMed     Abstract available
     
     
     
127. POWELL A, Sumnall H, Smith J, Kuiper R, et al
     Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Protocol for a systematic review of longitudinal studies.
     PLoS One. 2022;17:e0274752.
     PubMed     Abstract available
     
     
     
128. SUNG C, Chung CH, Lin FH, Chien WC, et al
     Risk of cardiovascular disease in patients with alcohol use disorder: A population-based retrospective cohort study.
     PLoS One. 2022;17:e0276690.
     PubMed     Abstract available
     
     
     
129. DE FREITAS MG, Silva END
     Direct and indirect costs attributed to alcohol consumption in Brazil, 2010 to 2018.
     PLoS One. 2022;17:e0270115.
     PubMed     Abstract available
     
     
     
130. GROBBEE EJ, de Jong VD, Schrieks IC, Tushuizen ME, et al
     Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-alpha/gamma agonist aleglitazar.
     PLoS One. 2022;17:e0277706.
     PubMed     Abstract available
     
     
     
131. MICHELSEN ME, Gronkjaer M, Mortensen EL, Wimmelmann CL, et al
     Social, psychological and health characteristics associated with stability and change in adult alcohol consumption.
     PLoS One. 2022;17:e0277511.
     PubMed     Abstract available
     
     
     
132. KIYOAKI I, Sumida Y, Nakade Y, Okumura A, et al
     Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis.
     PLoS One. 2022;17:e0277380.
     PubMed     Abstract available
     
     
     
133. NEUFELD M, Ferreira-Borges C, Bunova A, Gornyi B, et al
     Capturing Russian drinking patterns with the Alcohol Use Disorders Identification Test: An exploratory interview study in primary healthcare and narcology centers in Moscow.
     PLoS One. 2022;17:e0274166.
     PubMed     Abstract available
     
     
     
134. SIMPSON TL, Kaysen DL, Fleming CB, Rhew IC, et al
     Cognitive Processing Therapy or Relapse Prevention for comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A randomized clinical trial.
     PLoS One. 2022;17:e0276111.
     PubMed     Abstract available
     
     
     
135. DUNGUBAT E, Kusano H, Mori I, Tawara H, et al
     Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice.
     PLoS One. 2022;17:e0278580.
     PubMed     Abstract available
     
     
     
136. ABOAGYE RG, Ahinkorah BO, Tengan CL, Salifu I, et al
     Partner alcohol consumption and intimate partner violence against women in sexual unions in sub-Saharan Africa.
     PLoS One. 2022;17:e0278196.
     PubMed     Abstract available
     
     
     
137. KASSEW T, Liyew B, Tarekegn GE, Wondie M, et al
     Spatial distribution and determinants of alcohol consumption among pregnant women in Ethiopia: Spatial and multilevel analysis.
     PLoS One. 2022;17:e0279405.
     PubMed     Abstract available
     
     
     
138. SHANGANI S, van den Berg JJ, Dyer TV, Mayer KH, et al
     Childhood sexual abuse, alcohol and drug use problems among Black sexual minority men in six US Cities: Findings from the HPTN 061 study.
     PLoS One. 2022;17:e0279238.
     PubMed     Abstract available
     
     
     January 2021
139. PEDRONI C, Dujeu M, Lebacq T, Desnouck V, et al
     Alcohol consumption in early adolescence: Associations with sociodemographic and psychosocial factors according to gender.
     PLoS One. 2021;16:e0245597.
     PubMed     Abstract available
     
     
     
140. ESTRADA-MARTINEZ S, Perez-Alamos AR, Ibarra-Segovia M, Beristain-Garcia I, et al
     Seroepidemiology of Toxoplasma gondii infection in people with alcohol consumption in Durango, Mexico.
     PLoS One. 2021;16:e0245701.
     PubMed     Abstract available
     
     
     
141. LIN X, You F, Liu H, Fang Y, et al
     Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
     PLoS One. 2021;16:e0245921.
     PubMed     Abstract available
     
     
     
142. 
     Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
     PLoS One. 2021;16:e0247690.
     PubMed     Abstract available
     
     
     
143. HENNEIN R, Mew EJ, Lowe SR
     Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States.
     PLoS One. 2021;16:e0246602.
     PubMed     Abstract available
     
     
     
144. DARLING KEA, Locatelli I, Benghalem N, Nadin I, et al
     Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
     PLoS One. 2021;16:e0246579.
     PubMed     Abstract available
     
     
     
145. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
     A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
     PLoS One. 2021;16:e0249316.
     PubMed     Abstract available
     
     
     
146. ARIYA M, Koohpayeh F, Ghaemi A, Osati S, et al
     Assessment of the association between body composition and risk of non-alcoholic fatty liver.
     PLoS One. 2021;16:e0249223.
     PubMed     Abstract available
     
     
     
147. KURODA H, Fujiwara Y, Abe T, Nagasawa T, et al
     Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
     PLoS One. 2021;16:e0249493.
     PubMed     Abstract available
     
     
     
148. D'AMBROSIO R, Campi I, Maggioni M, Perbellini R, et al
     The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
     PLoS One. 2021;16:e0249614.
     PubMed     Abstract available
     
     
     
149. BAE CR, Zhang H, Kwon YG
     Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
     PLoS One. 2021;16:e0249747.
     PubMed     Abstract available
     
     
     
150. KOUTOUKIDIS DA, Morris E, Henry JA, Shammoon Y, et al
     What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
     PLoS One. 2021;16:e0250385.
     PubMed     Abstract available
     
     
     
151. TAHA MM, Aneis YM, Mohamady HM, S A A, et al
     Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
     PLoS One. 2021;16:e0250337.
     PubMed     Abstract available
     
     
     
152. CONGLY SE, Shaheen AA, Swain MG
     Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.
     PLoS One. 2021;16:e0251741.
     PubMed     Abstract available
     
     
     
153. YEN HH, Su PY, Huang SP, Wu L, et al
     Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
     PLoS One. 2021;16:e0252286.
     PubMed     Abstract available
     
     
     
154. KIM JY, Park YM, Lee GN, Song HC, et al
     Association between toothbrushing and non-alcoholic fatty liver disease.
     PLoS One. 2021;16:e0243686.
     PubMed     Abstract available
     
     
     
155. DAYTON KA, Bril F, Barb D, Lai J, et al
     Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
     PLoS One. 2021;16:e0251449.
     PubMed     Abstract available
     
     
     
156. RENNERT-MAY E, Leal J, Thanh NX, Lang E, et al
     The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study.
     PLoS One. 2021;16:e0252441.
     PubMed     Abstract available
     
     
     
157. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
     Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
     PLoS One. 2021;16:e0253298.
     PubMed     Abstract available
     
     
     
158. MORAN MW, Ramirez EP, Zook JD, Saarinen AM, et al
     Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease.
     PLoS One. 2021;16:e0249164.
     PubMed     Abstract available
     
     
     
159. PRO G, Gilbert PA, Baldwin JA, Brown CC, et al
     Multilevel modeling of county-level excessive alcohol use, rurality, and COVID-19 case fatality rates in the US.
     PLoS One. 2021;16:e0253466.
     PubMed     Abstract available
     
     
     
160. YOKOYAMA A, Yokoyama T, Kimura M, Matsushita S, et al
     Combinations of alcohol-induced flushing with genetic polymorphisms of alcohol and aldehyde dehydrogenases and the risk of alcohol dependence in Japanese men and women.
     PLoS One. 2021;16:e0255276.
     PubMed     Abstract available
     
     
     
161. LEE Y, Mun E, Park S, Lee W, et al
     Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study.
     PLoS One. 2021;16:e0255118.
     PubMed     Abstract available
     
     
     
162. ERIKSEN LL, Nielsen MA, Laursen TL, Deleuran B, et al
     Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis.
     PLoS One. 2021;16:e0255574.
     PubMed     Abstract available
     
     
     
163. MANTHEY J, Solovei A, Anderson P, Carr S, et al
     Can alcohol consumption in Germany be reduced by alcohol screening, brief intervention and referral to treatment in primary health care? Results of a simulation study.
     PLoS One. 2021;16:e0255843.
     PubMed     Abstract available
     
     
     
164. MINICOZZI MR, Axlid EG, von Hippel FA, Espinoza J, et al
     Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
     PLoS One. 2021;16:e0254500.
     PubMed     Abstract available
     
     
     
165. DANTAS DMM, Cahu TB, Oliveira CYB, Abadie-Guedes R, et al
     Chlorella vulgaris functional alcoholic beverage: Effect on propagation of cortical spreading depression and functional properties.
     PLoS One. 2021;16:e0255996.
     PubMed     Abstract available
     
     
     
166. GAUME J, Grazioli VS, Paroz S, Fortini C, et al
     Developing a brief motivational intervention for young adults admitted with alcohol intoxication in the emergency department - Results from an iterative qualitative design.
     PLoS One. 2021;16:e0246652.
     PubMed     Abstract available
     
     
     
167. O'DONNELL A, Schulte B, Manthey J, Schmidt CS, et al
     Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America.
     PLoS One. 2021;16:e0255594.
     PubMed     Abstract available
     
     
     
168. VAN DEN TOREN SJ, van Grieken A, Raat H
     Associations of socio-demographic characteristics, well-being, school absenteeism, and substance use with recreational nitrous oxide use among adolescents: A cross-sectional study.
     PLoS One. 2021;16:e0247230.
     PubMed     Abstract available
     
     
     
169. LI M, Hu M, Yue Z, Zhang Y, et al
     The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
     PLoS One. 2021;16:e0257391.
     PubMed     Abstract available
     
     
     
170. KAPS L, Ahlbrand CJ, Gadban R, Nagel M, et al
     Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
     PLoS One. 2021;16:e0249342.
     PubMed     Abstract available
     
     
     
171. WANG IJ, Bae BK, Cho YM, Cho SJ, et al
     Effect of acute alcohol intoxication on mortality, coagulation, and fibrinolysis in trauma patients.
     PLoS One. 2021;16:e0248810.
     PubMed     Abstract available
     
     
     
172. HANNA CHAIM C, Santana GL, de Vries Albertin P, Silveira CM, et al
     Alcohol use patterns and disorders among individuals with personality disorders in the Sao Paulo Metropolitan Area.
     PLoS One. 2021;16:e0248403.
     PubMed     Abstract available
     
     
     
173. JACKSON J, Donaldson DI, Dering B
     The morning after the night before: Alcohol-induced blackouts impair next day recall in sober young adults.
     PLoS One. 2021;16:e0250827.
     PubMed     Abstract available
     
     
     
174. KNIGHT JK, Salali GD, Sikka G, Derkx I, et al
     Quantifying patterns of alcohol consumption and its effects on health and wellbeing among BaYaka hunter-gatherers: A mixed-methods cross-sectional study.
     PLoS One. 2021;16:e0258384.
     PubMed     Abstract available
     
     
     
175. OSCAR-BERMAN M, Ruiz SM, Marinkovic K, Valmas MM, et al
     Brain responsivity to emotional faces differs in men and women with and without a history of alcohol use disorder.
     PLoS One. 2021;16:e0248831.
     PubMed     Abstract available
     
     
     
176. 
     Retraction: Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
     PLoS One. 2021;16:e0259219.
     PubMed    
     
     
     
177. KASHYAP GC, Govind B, Srivastava S, R V, et al
     A true face of Indian married couples: Effect of age and education on control over own sexuality and sexual violence.
     PLoS One. 2021;16:e0254005.
     PubMed     Abstract available
     
     
     
178. HEITMANN J, van Hemel-Ruiter ME, Huisman M, Ostafin BD, et al
     Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial.
     PLoS One. 2021;16:e0252494.
     PubMed     Abstract available
     
     
     
179. CHARTIER KG, Guidry JPD, Lee CA, Buckley TD, et al
     At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults.
     PLoS One. 2021;16:e0259947.
     PubMed     Abstract available
     
     
     
180. HOLMES HM, Jove AG, Tan MC, El-Serag HB, et al
     Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population.
     PLoS One. 2021;16:e0260019.
     PubMed     Abstract available
     
     
     
181. HOWLETT N, Garcia-Iglesias J, Breslin G, Bartington S, et al
     Remote delivery of alcohol and/or substance misuse interventions for adults: A systematic review protocol.
     PLoS One. 2021;16:e0259525.
     PubMed     Abstract available
     
     
     
182. FILLMORE N, Bell S, Shen C, Nguyen V, et al
     Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.
     PLoS One. 2021;16:e0259061.
     PubMed     Abstract available
     
     
     
183. LEGAS G, Asnakew S, Belete A, Beyene GM, et al
     Magnitude and correlates of alcohol use disorder in south Gondar zone, northwest Ethiopia: A community based cross-sectional study.
     PLoS One. 2021;16:e0257804.
     PubMed     Abstract available
     
     
     
184. MINNERLY C, Shokry IM, To W, Callanan JJ, et al
     Characteristic changes in EEG spectral powers of patients with opioid-use disorder as compared with those with methamphetamine- and alcohol-use disorders.
     PLoS One. 2021;16:e0248794.
     PubMed     Abstract available
     
     
     
185. AGUERREBERE M, Frias SM, Smith Fawzi MC, Lopez R, et al
     Intimate partner violence types and symptoms of common mental disorders in a rural community of Chiapas, Mexico: Implications for global mental-health practice.
     PLoS One. 2021;16:e0256850.
     PubMed     Abstract available
     
     
     
186. GUTEMA H, Debela Y, Walle B, Reba K, et al
     Predicting binge drinking among university students: Application of integrated behavioral model.
     PLoS One. 2021;16:e0254185.
     PubMed     Abstract available
     
     
     
187. GOYALE A, Jain A, Smith C, Papatheodoridi M, et al
     Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
     PLoS One. 2021;16:e0260313.
     PubMed     Abstract available
     
     
     
188. JANG DK, Ahn DW, Lee KL, Kim BG, et al
     Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
     PLoS One. 2021;16:e0260309.
     PubMed     Abstract available
     
     
     
189. KONRAD G, Leong C, Bolton JM, Prior HJ, et al
     Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study.
     PLoS One. 2021;16:e0257025.
     PubMed     Abstract available
     
     
     
190. ALVES RM, Santos EGO, Barbosa IR
     Abuse of alcohol among farmers: Prevalence and associated factors.
     PLoS One. 2021;16:e0254904.
     PubMed     Abstract available
     
     
     
191. CORDOBA E, Garofalo R, Kuhns LM, Pearson C, et al
     Risk-taking behaviors in adolescent men who have sex with men (MSM): An association between homophobic victimization and alcohol consumption.
     PLoS One. 2021;16:e0260083.
     PubMed     Abstract available
     
     
     
192. ESKRIDGE W, Vierling JM, Gosbee W, Wan GA, et al
     Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).
     PLoS One. 2021;16:e0260320.
     PubMed     Abstract available
     
     
     
193. PARK SJ, Lee SJ, Kim H, Kim JK, et al
     Machine learning prediction of dropping out of outpatients with alcohol use disorders.
     PLoS One. 2021;16:e0255626.
     PubMed     Abstract available
     
     
     
194. VIGOUROUX A, Garret C, Lascarrou JB, Martin M, et al
     Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors.
     PLoS One. 2021;16:e0261443.
     PubMed     Abstract available
     
     
     
195. TEVIK K, Bergh S, Selbaek G, Johannessen A, et al
     A systematic review of self-report measures used in epidemiological studies to assess alcohol consumption among older adults.
     PLoS One. 2021;16:e0261292.
     PubMed     Abstract available
     
     
     
196. MCCRABB S, Mooney K, Wolfenden L, Gonzalez S, et al
     "He who pays the piper calls the tune": Researcher experiences of funder suppression of health behaviour intervention trial findings.
     PLoS One. 2021;16:e0255704.
     PubMed     Abstract available
     
     
     
197. PERALES JC, Maldonado A, Lopez-Quirantes EM, Lopez-Torrecillas F, et al
     Association patterns of cannabis abuse and dependence with risk of problematic non-substance-related dysregulated and addictive behaviors.
     PLoS One. 2021;16:e0255872.
     PubMed     Abstract available
     
     
     
198. CHEN Y, Hinton C, VanderWeele TJ
     School types in adolescence and subsequent health and well-being in young adulthood: An outcome-wide analysis.
     PLoS One. 2021;16:e0258723.
     PubMed     Abstract available
     
     
     
199. SINGINI MG, Sitas F, Bradshaw D, Chen WC, et al
     Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa.
     PLoS One. 2021;16:e0260319.
     PubMed     Abstract available
     
     
     
200. AKOMBI-INYANG B, Ghimire PR, Archibong E, Woolley E, et al
     Association between intimate partner violence and male alcohol use and the receipt of perinatal care: Evidence from Nepal demographic and health survey 2011-2016.
     PLoS One. 2021;16:e0259980.
     PubMed     Abstract available
     
     
     
201. RIBEIRO RM, Havik PJ, Craveiro I
     The circuits of healthcare: Understanding healthcare seeking behaviour-A qualitative study with tuberculosis patients in Lisbon, Portugal.
     PLoS One. 2021;16:e0261688.
     PubMed     Abstract available
     
     
     
202. RODRIGUES R, Lopez-Caneda E, Almeida-Antunes N, Sampaio A, et al
     Portuguese validation of the Alcohol Craving Questionnaire-Short Form-Revised.
     PLoS One. 2021;16:e0251733.
     PubMed     Abstract available
     
     
     January 2020
203. SAWYER KS, Adra N, Salz DM, Kemppainen MI, et al
     Hippocampal subfield volumes in abstinent men and women with a history of alcohol use disorder.
     PLoS One. 2020;15:e0236641.
     PubMed     Abstract available
     
     
     
204. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
     Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
     PLoS One. 2020;15:e0240867.
     PubMed     Abstract available
     
     
     
205. CHEN F, Xiao M, Chen C, Chen C, et al
     Discrimination of alcohol dependence based on the convolutional neural network.
     PLoS One. 2020;15:e0241268.
     PubMed     Abstract available
     
     
     
206. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
     Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
     PLoS One. 2020;15:e0241357.
     PubMed     Abstract available
     
     
     
207. HENNEIN R, Lowe S
     A hybrid inductive-abductive analysis of health workers' experiences and wellbeing during the COVID-19 pandemic in the United States.
     PLoS One. 2020;15:e0240646.
     PubMed     Abstract available
     
     
     
208. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
     Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
     PLoS One. 2020;15:e0242582.
     PubMed     Abstract available
     
     
     
209. ADRAWA N, Alege JB, Izudi J
     Alcohol consumption increases non-adherence to ART among people living with HIV enrolled to the community-based care model in rural northern Uganda.
     PLoS One. 2020;15:e0242801.
     PubMed     Abstract available
     
     
     
210. BAE CR, Zhang H, Kwon YG
     The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
     PLoS One. 2020;15:e0243497.
     PubMed     Abstract available
     
     
     
211. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
     Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
     PLoS One. 2020;15:e0240090.
     PubMed     Abstract available
     
     
     
212. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
     Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
     PLoS One. 2020;15:e0240338.
     PubMed     Abstract available
     
     
     
213. VORNHOLT E, Drake J, Mamdani M, McMichael G, et al
     Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC.
     PLoS One. 2020;15:e0243857.
     PubMed     Abstract available
     
     
     
214. RADCLIFFE RA, Dowell R, Odell AT, Richmond PA, et al
     Systems genetics analysis of the LXS recombinant inbred mouse strains:Genetic and molecular insights into acute ethanol tolerance.
     PLoS One. 2020;15:e0240253.
     PubMed     Abstract available
     
     
     
215. FRANK K, Abeynaike S, Nikzad R, Patel RR, et al
     Alcohol dependence promotes systemic IFN-gamma and IL-17 responses in mice.
     PLoS One. 2020;15:e0239246.
     PubMed     Abstract available
     
     
     
216. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
     Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
     PLoS One. 2020;15:e0244514.
     PubMed     Abstract available
     
     
     
217. KILIAN C, Manthey J, Moskalewicz J, Scafato E, et al
     Comparing subjective intoxication with risky single-occasion drinking in a European sample.
     PLoS One. 2020;15:e0241433.
     PubMed     Abstract available
     
     
     
218. LONG JE, Richardson BA, Wanje G, Wilson KS, et al
     Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
     PLoS One. 2020;15:e0242817.
     PubMed     Abstract available
     
     
     
219. TAVANASEFAT H, Li F, Koyano K, Gourtani BK, et al
     Molecular consequences of fetal alcohol exposure on amniotic exosomal miRNAs with functional implications for stem cell potency and differentiation.
     PLoS One. 2020;15:e0242276.
     PubMed     Abstract available
     
     
     
220. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
     Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
     PLoS One. 2020;15:e0240595.
     PubMed     Abstract available
     
     
     
221. SEGHER K, Huys L, Desmet T, Steen E, et al
     Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.
     PLoS One. 2020;15:e0243222.
     PubMed     Abstract available
     
     
     
222. BITEW MS, Zewde MF, Wubetu M, Alemu AA, et al
     Consumption of alcohol and binge drinking among pregnant women in Addis Ababa, Ethiopia: Prevalence and determinant factors.
     PLoS One. 2020;15:e0243784.
     PubMed     Abstract available
     
     
     
223. IGLESIAS K, Lannoy S, Sporkert F, Daeppen JB, et al
     Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men.
     PLoS One. 2020;15:e0244336.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alcoholism is free of charge.